FDA issued a Warning Letter to Lonza Biologics, Inc. on 9/1/2011 as a result of this inspection.
FDA investigators audited the Lonza Biologics - Hopkinton, MA, United States facility and issued inspectional observations (via FDA 483) on 06 May 2011.
Product details
- Category: Human Drugs
- Inspection end: 06 May 2011
- Location: Hopkinton, United States
- FEI: 3001701602
